Items where authors include "Cornec-Le Gall, E."

Number of items: 10.

Article

Devuyst, O. orcid.org/0000-0003-3744-4767, Ahn, C., Barten, T.R.M. et al. (24 more authors) (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney International, 107 (2). S1-S239. ISSN 0085-2538

Torres, V.E., Ahn, C., Barten, T.R.M. et al. (27 more authors) (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney International, 107 (2). pp. 234-254. ISSN 0085-2538

Zagorec, N., Calamel, A., Delaporte, M. et al. (24 more authors) (2024) Clinical spectrum and prognosis of atypical autosomal dominant polycystic kidney disease caused by monoallelic pathogenic variants of IFT140. American Journal of Kidney Diseases. ISSN 0272-6386

Taylor, J., Thomas, R., Metherall, P. et al. (15 more authors) (2024) An artificial intelligence generated automated algorithm to measure total kidney volume in ADPKD. Kidney International Reports, 9 (2). pp. 249-256. ISSN 2468-0249

Müller, R.-U., Lianne Messchendorp, A., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Kidneys, 11 (1). pp. 37-39. ISSN 2307-1257

Müller, R.-U., Messchendorp, A.L., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrology Dialysis Transplantation, 37 (5). pp. 825-839. ISSN 0931-0509

Senum, S.R., Li, Y.S.M., Benson, K.A. et al. (25 more authors) (2022) Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. The American Journal of Human Genetics, 109 (1). pp. 136-156. ISSN 0002-9297

Huynh, V.T., Audrézet, M.-P., Sayer, J.A. et al. (17 more authors) (2020) Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease. Kidney International, 98 (2). pp. 476-487. ISSN 0085-2538

Hopp, K. orcid.org/0000-0002-2420-2358, Cornec-Le Gall, E., Senum, S.R. orcid.org/0000-0002-5489-9117 et al. (17 more authors) (2020) Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease. Kidney International, 97 (2). pp. 370-382. ISSN 0085-2538

Proceedings Paper

Winterbottom, J., Simms, R., Caroli, A. et al. (10 more authors) (2021) MO023: Flank pain has a major negative impact on health-related quality of life in ADPKD: The CYSTic I Study. In: Nephrology Dialysis Transplantation. 58th ERA-EDTA Congress, 05-08 Jun 2021, Berlin, Germany. Oxford University Press , i102.

This list was generated on Tue Apr 1 18:21:53 2025 BST.